| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.79B | 62.41B | 58.70B | 57.98B | 55.02B | 66.62B |
| Gross Profit | 4.30B | 4.20B | 3.68B | 3.68B | 3.73B | 3.89B |
| EBITDA | 769.25M | 797.00M | 572.00M | 642.00M | 651.00M | 1.02B |
| Net Income | 352.00M | 287.00M | 204.00M | 223.00M | 264.00M | 518.00M |
Balance Sheet | ||||||
| Total Assets | 18.45B | 16.60B | 17.18B | 16.87B | 15.81B | 15.56B |
| Cash, Cash Equivalents and Short-Term Investments | 1.07B | 856.00M | 1.39B | 1.02B | 1.25B | 1.33B |
| Total Debt | 6.61B | 4.96B | 4.50B | 5.23B | 5.15B | 5.33B |
| Total Liabilities | 11.78B | 10.06B | 10.77B | 10.69B | 10.00B | 9.85B |
| Stockholders Equity | 6.67B | 6.54B | 6.42B | 6.18B | 5.81B | 5.70B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -683.00M | 994.00M | -425.00M | -49.00M | 190.00M |
| Operating Cash Flow | 0.00 | -449.00M | 1.20B | 143.00M | 272.00M | 379.00M |
| Investing Cash Flow | 0.00 | -354.00M | -1.00M | -358.00M | -76.00M | 685.00M |
| Financing Cash Flow | 0.00 | 272.00M | -833.00M | -14.00M | -309.00M | -464.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥32.60B | 9.72 | ― | 1.94% | 3.15% | 27.71% | |
69 Neutral | ¥165.06B | 9.61 | ― | 1.39% | 3.91% | -0.28% | |
68 Neutral | ¥16.78B | 2.44 | ― | 3.17% | 5.19% | 11.04% | |
64 Neutral | ¥70.86B | 21.73 | ― | 1.48% | 8.41% | -3.65% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥9.15B | 12.72 | ― | 0.95% | 6.26% | 67.81% | |
61 Neutral | ¥49.41B | 3.77 | ― | 0.52% | 20.97% | -56.39% |